News & Events
Press Releases
In the News
Events
Delivering a New “Post-COVID” Generation of RNA Therapeutics
October 14, 2022

SiSaf to seek FDA Orphan Drug Designation for SIS-101-ADO
October 13, 2022

The challenges and trends of cell & gene therapies
September 6, 2022

Delivering a New “Post-COVID” Generation of RNA Therapeutics
October 14, 2022

SiSaf to seek FDA Orphan Drug Designation for SIS-101-ADO
October 13, 2022

The challenges and trends of cell & gene therapies
September 6, 2022

2nd Annual mRNA-Based Therapeutics Summit Europe
Berlin
January 24 – 26, 2023
Attending:
Dr Suzanne Saffie-Siebert, CEO
JPM 2023 41st Annual Healthcare Meeting
San Francisco
January 9 – 12, 2023
Attending:
Dr Suzanne Saffie-Siebert, CEO
Richard Scarrott, CFO
Dr Suzanne Saffie-Siebert, CEO
Richard Scarrott, CFO
BIO-Europe
Berlin
October 24 – 26, 2022
Attending:
Dr Michael Welsh, CSO
Dr Spiros Servos, BD
Dr Michael Welsh, CSO
Dr Spiros Servos, BD
RNA Leaders USA Congress
Boston
October 18 – 19, 2022
Attending:
Dr Suzanne Saffie-Siebert, CEO
Richard Scarrott, CFO
ARM Cell & Gene Meeting on the Mesa
October 11 – 13, 2022
Attending:
Dr Spiros Servos, BD
Dr Spiros Servos, BD
JPM 2023 41st Annual Healthcare Meeting
San Francisco
January 9 – 12, 2023
Attending:
Dr Suzanne Saffie-Siebert, CEO
Richard Scarrott CFO
Dr Suzanne Saffie-Siebert, CEO
Richard Scarrott CFO
BIO-Europe
October 24 – 26, 2022
Attending:
Dr Michael Welsh, CSO
Dr Spiros Servos, BD
Dr Michael Welsh, CSO
Dr Spiros Servos, BD
RNA Leaders USA Congress
October 18 -19, 2022
Attending:
Dr Suzanne Saffie-Siebert, CEO
Richard Scarrott, CFO
Dr Suzanne Saffie-Siebert, CEO
Richard Scarrott, CFO
ARM Cell & Gene Meeting on the Mesa
October 11 – 13, 2022
Attending:
Dr Spiros Servos, BD
Dr Spiros Servos, BD